Sanofi India Ltd

Company Profile

Sanofi India Ltd had its IPO on under the ticker symbol SANOFI.

The company operates in the Healthcare sector and Pharmaceuticals industry. Sanofi India Ltd has a staff strength of 3,426 employees.

Stock update

Shares of Sanofi India Ltd opened at ₹7092 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹6961.35 - ₹7173, and closed at ₹7145.95.

This is a +0.51% increase from the previous day's closing price.

A total volume of 1,989 shares were traded at the close of the day’s session.

In the last one week, shares of Sanofi India Ltd have increased by +0.5%.

Sanofi India Ltd's Key Ratios

Sanofi India Ltd has a market cap of ₹146.16 billion, indicating a price to book ratio of 9.311 and a price to sales ratio of 4.918.

In the last 12-months Sanofi India Ltd’s revenue was ₹31.00 billion with a gross profit of ₹16.92 billion and an EBITDA of ₹7.08 billion. The EBITDA ratio measures Sanofi India Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Sanofi India Ltd’s operating margin was 20.02% while its return on assets stood at 11.98% with a return of equity of 0%.

In Q4, Sanofi India Ltd’s quarterly earnings growth was a positive 39.9% while revenue growth was a negative 5%.

Sanofi India Ltd’s PE and PEG Ratio

Forward PE

0

Trailing PE

32.7977

PEG

Its diluted EPS in the last 12-months stands at ₹193.497 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Sanofi India Ltd’s profitability.

Sanofi India Ltd stock is trading at a EV to sales ratio of 4.6723 and a EV to EBITDA ratio of 15.1282. Its price to sales ratio in the trailing 12-months stood at 4.918.

Sanofi India Ltd stock pays annual dividends of ₹66 per share, indicating a yield of 1.02% and a payout ratio of 2.33%.

Balance sheet and cash flow metrics

Total Assets

₹20.72 billion

Total Liabilities

₹7.41 billion

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

2.33%

Sanofi India Ltd ended 2024 with ₹20.72 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹20.72 billion while shareholder equity stood at ₹12.76 billion.

Sanofi India Ltd ended 2024 with ₹0 in deferred long-term liabilities, ₹7.41 billion in other current liabilities, in common stock, ₹8.43 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹10.05 billion and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

Sanofi India Ltd’s total current assets stands at ₹16.10 billion while long-term investments were ₹0 and short-term investments were ₹190.00 million. Its net receivables were ₹1.29 billion compared to accounts payable of ₹3.56 billion and inventory worth ₹4.08 billion.

In 2024, Sanofi India Ltd's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Sanofi India Ltd paid ₹0.02 in dividends in 2024.

Other key metrics

Current Trading Price

₹7145.95

52-Week High

₹6593.0724

52-Week Low

₹5069.6777

Analyst Target Price

₹

Sanofi India Ltd stock is currently trading at ₹7145.95 per share. It touched a 52-week high of ₹6593.0724 and a 52-week low of ₹6593.0724. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹7051.61 and 200-day moving average was ₹6135.55 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 6037.5% of the company’s stock are held by insiders while 2540.9% are held by institutions.